Analyst Ratings for Capricor Therapeutics (CAPR)
CAPR Rating Summary
CAPR Price Target Summary
- Highest: $63.00 (B.Riley)
- Lowest: $12.00 (Roth/MKM)
- Average: $47.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$47.50 (+67.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$47.50 (+67.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/30/2025 | Alliance Global Partners | Matt Venezia | New Coverage | Buy (N/A) |
20.00 (N/A) |
11.15 (28.36) |
154.35% | Details |
| 6/26/2025 | B.Riley » Updated 5/13/2026 |
Madison El-Saadi | New Coverage | Buy (N/A) |
63.00 (N/A) |
9.25 (28.36) |
206.59% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
